ARCHIVES

Experts Say Interpretable Results Unlikely In Burzynski’s Antineoplastons Studies

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

Carcinogenicity Test For Cis-Platinum Needed, DCT Says, But Declines To Pay For It

June 16, 1978

RFPs Go Out To Cooperative Groups for Community Programs

April 9, 1976

In Brief: Peter Fischinger Names NCI Deputy Director; ACR Moves Headquarters To Washington Area

November 8, 1985

Markison leaving Bristol-Myers, two others promoted in reorganization.

January 30, 2004

Avastin Regimen Bested Chemo Alone In Early Disease

January 31, 2003

Tim Lee Carter Named Chairman Of NCAB; Five Others Appointed

June 11, 1982